Literature DB >> 17444618

Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.

Steffen Runge1, Susann Schimmer, Jan Oschmann, Christine Bruun Schiødt, Sanne Möller Knudsen, Claus Bekker Jeppesen, Kjeld Madsen, Jesper Lau, Henning Thøgersen, Rainer Rudolph.   

Abstract

Glucagon-like peptide-1 (GLP-1) and exendin-4 (Ex4) are homologous peptides with established potential for treatment of type 2 diabetes. They bind and activate the pancreatic GLP-1 receptor (GLP-1R) with similar affinity and potency and thereby promote insulin secretion in a glucose-dependent manner. GLP-1R belongs to family B of the seven transmembrane G-protein coupled receptors. The N-terminal extracellular domain (nGLP-1R) is a ligand binding domain with differential affinity for Ex4 and GLP-1: low affinity for GLP-1 and high affinity for exendin-4. The superior affinity of nGLP-1R for Ex4 was previously explained by an additional interaction between nGLP-1R and the C-terminal Trp-cage of Ex4. In this study we have combined biophysical and pharmacological approaches thus relating structural properties of the ligands in solution to their relative binding affinity for nGLP-1R. We used both a tracer competition assay and ligand-induced thermal stabilization of nGLP-1R to measure the relative affinity of full length, truncated, and chimeric ligands for soluble refolded nGLP-1R. The ligands in solution and the conformational consequences of ligand binding to nGLP-1R were characterized by circular dichroism and fluorescence spectroscopy. We found a correlation between the helical content of the free ligands and their relative binding affinity for nGLP-1R, supporting the hypothesis that the ligands are helical at least in the segment that binds to nGLP-1R. The Trp-cage of Ex4 was not necessary to maintain a superior helicity of Ex4 compared to GLP-1. The results suggest that the differential affinity of nGLP-1R is explained almost entirely by divergent residues in the central part of the ligands: Leu10-Gly30 of Ex4 and Val16-Arg36 of GLP-1. In view of our results it appears that the Trp-cage plays only a minor role for the interaction between Ex4 and nGLP-1R and for the differential affinity of nGLP-1R for GLP-1 and Ex4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444618     DOI: 10.1021/bi062309m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.

Authors:  R J Mann; N E Nasr; J K Sinfield; E Paci; D Donnelly
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery.

Authors:  Samagya Banskota; Parisa Yousefpour; Nadia Kirmani; Xinghai Li; Ashutosh Chilkoti
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

4.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

Review 5.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).

Authors:  Dehua Yang; Chris de Graaf; Linlin Yang; Gaojie Song; Antao Dai; Xiaoqing Cai; Yang Feng; Steffen Reedtz-Runge; Michael A Hanson; Huaiyu Yang; Hualiang Jiang; Raymond C Stevens; Ming-Wei Wang
Journal:  J Biol Chem       Date:  2016-04-08       Impact factor: 5.157

Review 7.  Biophysical characterization of G-protein coupled receptor-peptide ligand binding.

Authors:  David N Langelaan; Pascaline Ngweniform; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2011-04       Impact factor: 3.626

8.  The predicted binding site and dynamics of peptide inhibitors to the Methuselah GPCR from Drosophila melanogaster.

Authors:  Jiyoung Heo; William W Ja; Seymour Benzer; William A Goddard
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

9.  Exenatide: a new promising antidiabetic agent.

Authors:  C K Chakraborti
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

10.  Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.

Authors:  Jason G Barrera; David A D'Alessio; Daniel J Drucker; Stephen C Woods; Randy J Seeley
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.